Evidence map›Paper›PMID 41740161›Full record

ArticleJMIR formative research2026

Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM).

Alexis Talbot, Bernard Delcour, Laurent Gillot, Bertrand Arnulf, Hervé Avet Loiseau, Catherine Boccaccio, Laurent Frenzel, Lionel Karlin, Karen Kraeuter, Margaret Macro and 7 more

Abstract read
In one paragraph

Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alexis TalbotUCSF Helen Diller Family Comprehensive Cancer Center, Parnassus Avenue, San Francisco, CA, United States, 1 4156239672.ORCID http://orcid.org/0000-0001-6734-413X
Bernard DelcourFrench Association of Patients with Multiple Myeloma (AF3M), Paris, France.ORCID http://orcid.org/0009-0001-6420-0939
Laurent GillotFrench Association of Patients with Multiple Myeloma (AF3M), Paris, France.ORCID http://orcid.org/0009-0005-0423-3631
Bertrand ArnulfHopital Saint Louis, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.ORCID http://orcid.org/0000-0001-7719-3611
Hervé Avet LoiseauUnite de Genomique du Myélome, Institut National de la Santé et de la Recherche Medicale, University Cancer Center of Toulouse, Toulouse, France.ORCID http://orcid.org/0000-0002-3050-0140
Catherine BoccaccioIntergroupe Francophone du Myélome, Paris, France.ORCID http://orcid.org/0009-0003-9792-9747
Laurent FrenzelHopital Necker, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.ORCID http://orcid.org/0000-0002-6085-2163
Lionel KarlinCentre Hospitalier Lyon Sud, Lyon, France.ORCID http://orcid.org/0000-0002-1185-4488
Karen KraeuterOnco-psychologist, Bordeaux, France.ORCID http://orcid.org/0009-0000-3913-4899
Margaret MacroHematology department, CHU CAEN, Caen, France.ORCID http://orcid.org/0000-0002-0460-0658
Mohamad MohtyHematology department, Hopital Saint Antoine, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.ORCID http://orcid.org/0000-0002-7264-808X
Aurore PerrotUniversité de Toulouse, CHU de Toulouse, Hématologie, IUCT-Oncopole CRCT, Toulouse, France.ORCID http://orcid.org/0000-0003-0131-8689
Cyrille TouzeauCHU de Nantes, Hôtel Dieu, Nantes, France.ORCID http://orcid.org/0000-0003-0275-2575
Cécile SonntagCHRU de Strasbourg, Hôpital Hautepierre, Strasbourg, France.ORCID http://orcid.org/0009-0001-1616-2501
Cyrille HulinHematology department, CHU Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0002-3749-5161
Philippe MoreauCHU de Nantes, Hôtel Dieu, Nantes, France.ORCID http://orcid.org/0000-0003-1780-8746
Olivier DecauxHematology department, CHRU Hôpital de Pontchaillou, Rennes, France.ORCID http://orcid.org/0000-0003-2361-9669

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple myeloma (MM) is a chronic hematologic malignancy characterized by complex therapeutic strategies, repeated relapses, and substantial information and psychosocial needs. Advances in oral therapies and outpatient management have shifted greater responsibility to patients and caregivers, emphasizing the need for accessible, high-quality educational resources. Therapeutic patient education (TPE) aims to empower patients to understand and manage their condition more effectively. Digital education tools such as massive open online courses (MOOCs) represent an innovative approach to deliver structured, interactive, and scalable learning experiences to large patient populations. However, few MOOCs have been specifically designed for patients with oncological or hematological disorders, and even fewer have been rigorously evaluated for their educational impact. Objective: This study aimed to develop and evaluate a MOOC co-designed with patients, caregivers, and health care professionals to improve knowledge, skills, and empowerment among patients living with MM and their relatives. Secondary objectives included assessing participant satisfaction, engagement, and the feasibility of this digital education model at a national scale. Methods: The MOOC "Understanding and Living with Myeloma" was jointly developed by the French Association of Patients with Multiple Myeloma (AF3M) and the French-Speaking Myeloma Intergroup (IFM). The program consisted of 5 thematic modules delivered over 8 weeks, covering disease mechanisms, diagnosis, treatment options, side-effect management, and daily-life adaptation. Content combined educational videos, self-assessment quizzes, peer-tutoring forums, and live web conferences with experts. Participants self-assessed their knowledge using a 52-item questionnaire rated from 1 (poor) to 5 (excellent) before and after completing the program. Descriptive and inferential analyses were performed using the Wilcoxon signed-rank test (2-sided α=.05). Results: During the first session, 254 participants registered for the course. Among them, 76 (30%) completed all modules and both evaluations. The mean global knowledge score increased from 3.06/5 before to 4.21/5 after the MOOC (mean gain + 1.15, + 38%; P<.001). Improvements were consistent across all knowledge domains, including understanding of treatments (+40%), recognition of warning signs (+35%), and self-management skills (+39%). Overall, 98% (74/76) of respondents reported being satisfied or very satisfied with the course, and 99% (75/76) would recommend it to other patients. Since 2018, the MOOC has been conducted 6 times at different periods, enrolling a cumulative total of 2400 participants, confirming its sustainability and scalability. Conclusions: Participation in this co-designed, patient-centered MOOC was associated with a statistically and educationally significant improvement in knowledge among patients with MM and their caregivers. The program was highly valued by users and demonstrates the feasibility of large-scale digital patient education in oncology. As a freely accessible, repeatable, and peer-supported resource, this MOOC complements medical consultations and traditional TPE programs. Its design and outcomes may serve as a model for future digital health education initiatives targeting other chronic diseases.

Indexed as

massive open online coursemedical educationMOOCmultiple myelomapatienttherapeutic patient education

Identifiers

PMID41740161
PMCPMC12935415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.